Might the EPO’s Enlarged Board of Appeal step into the CRISPR patent battle and reconsider the “all applicants” approach?
Research output: Other contribution › Net publication - Internet publication › Communication
Standard
Might the EPO’s Enlarged Board of Appeal step into the CRISPR patent battle and reconsider the “all applicants” approach? / Wested, Jakob; Minssen, Timo; Van Zimmeren, Esther .
Harvard Law School's Bill of Health blog. 2018, Blog post.Research output: Other contribution › Net publication - Internet publication › Communication
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - ICOMM
T1 - Might the EPO’s Enlarged Board of Appeal step into the CRISPR patent battle and reconsider the “all applicants” approach?
AU - Wested, Jakob
AU - Minssen, Timo
AU - Van Zimmeren, Esther
PY - 2018/7
Y1 - 2018/7
N2 - The Broad Institute is facing a formidable task in defending the revoked CRISPR patent claims in their pending appeal at the EPO. Ultimately, some of the issues might still be referred to the Enlarged Board of Appeal. However, this might require a significant amount of legal and rhetorical agility.
AB - The Broad Institute is facing a formidable task in defending the revoked CRISPR patent claims in their pending appeal at the EPO. Ultimately, some of the issues might still be referred to the Enlarged Board of Appeal. However, this might require a significant amount of legal and rhetorical agility.
M3 - Net publication - Internet publication
PB - Harvard Law School's Bill of Health blog
ER -
ID: 199590381